Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer.

@article{Mohammad2015ReductionOH,
  title={Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer.},
  author={Nadia Haj Mohammad and Martijn Kamphuis and M. C. C. M. Hulshof and Lotte J Lutkenhaus and Suzanne S. Gisbertz and Jacques J. Bergman and H A C M Rianne de Bruin-Bon and Elisabeth D Geijsen and Arjan Bel and S Mathijs Boekholdt and Hanneke W. M. van Laarhoven},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2015},
  volume={114 1},
  pages={91-5}
}
BACKGROUND AND PURPOSE Neoadjuvant chemoradiation (nCRT) followed by surgery is considered curative intent treatment for patients with resectable esophageal cancer. The aim was to establish hemodynamic aspects of changes in heart volume and to explore whether changes in heart volume resulted in clinically relevant changes in the dose distribution of radiotherapy. METHODS A prospective study was conducted in patients who were treated with nCRT consisting of carboplatin and paclitaxel… CONTINUE READING